Loading…
scientists found that PIK3CA mutations alter methionine production in some breast cancer cells, making them dependent on the amino acid. The study, published in Science Signaling, points toward a possible new treatment approach.
This is biomedical research with no link to feed supply, demand or prices, so it has no market implication.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.